Minnesota company's 'pacemaker for the stomach' gets FDA approval for weight loss

Author:
Updated:
Original:

The first weight-loss device to gain U.S. regulatory approval in eight years is made by a Roseville company.

The Food and Drug Administration announced Wednesday it has approved the Maestro Rechargeable System for use by certain patients fighting obesity.

The maker of the device, EnteroMedics, says it is surgically implanted – much like a pacemaker – and stimulates the nerve that runs between the stomach and the brain, sending signals about how hungry or full the patient feels.

The FDA approved the device for patients who are 18 or older, have a body mass index of 35 to 45, and have been unable to shed pounds in a supervised weight management program during the previous five years. They also must have another health-related condition such as diabetes, high blood pressure, or high cholesterol.

The Maestro device has an external battery which needs to be recharged weekly, the Associated Press says.

Reuters reports that can be done by the patient, while a medical professional can adjust the device's settings with external controls.

An article from Middle East North Africa Financial Network notes this is only the third weight-loss device approved in the U.S. and it uses a different approach than the others, which limit how much food can fit in the stomach.

An obesity expert at The Mt. Sinai Hospital in New York says therapies like the Maestro system that alter the body's regulation of food intake are the wave of the future, the network reports.

Boost for EnteroMedics

The Star Tribune says the Maestro system is currently the only product made by EnteroMedics.

The company's stock price rose nearly 19 percent Wednesday on news of the FDA approval.

Bloomberg News reports the Maestro system still faces obstacles on the road to wider adoption, particularly since many insurance companies and government health programs have refused to cover weight-loss treatments.

A company executive tells Bloomberg the device is already approved in Europe and Australia but EnteroMedics plans to focus on its U.S. launch, targeting sales to surgical centers.

Next Up

Gary Kubiak

Vikings offensive coordinator Gary Kubiak announces retirement

Kubiak wraps up a career that has spanned nearly four decades.

alphaMPD

Minneapolis police seeks public help finding missing woman

A 63-year-old woman has been missing since Tuesday

coronavirus testing

Don't want to talk to a contact tracer? MN debuts online option after positive test

The department says the survey will allow its staff to keep track of more cases at a faster pace

Family Dollar

Money Gal Coaching: 12 things you are wasting your money on

Kelly Blodgett started Money Gal Coaching after paying down nearly $50K in debt in 18 months.

police lights

Three teens charged in Minneapolis robberies

The incidents took place on Saturday in Minneapolis.

covid-19, coronavirus, ppe

Here is Minnesota's COVID-19 update for Thursday, January 21

It's the first time in exactly four months that Minnesota has had fewer than 100 COVID patients in intensive care.

icy roads, bad roads

Girl, 16, killed in crash with semi on icy Minnesota road

The crash happened in Dodge County around 8 a.m. Wednesday.

police lights

Road rage incident sees driver punch out man's window, punch him in face

The incident happened in Waite Park Wednesday morning.

Screen Shot 2019-10-11 at 7.01.24 AM

Minneapolis will recover $100K in costs connected to 2019 Trump rally

The Target Center operator said it'll pay the costs over three years.

Jacob Frey

Minneapolis Mayor Jacob Frey confirms run for reelection

He has faced criticism over the city's response to George Floyd's death.

Related